Ajanta Pharma (BOM:532331) Total Liabilities : ₹10,710 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Total Liabilities?

Ajanta Pharma's Total Liabilities for the quarter that ended in Mar. 2024 was ₹10,710 Mil.

Ajanta Pharma's quarterly Total Liabilities declined from Sep. 2023 (₹9,513.60 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹10,710.30 Mil).

Ajanta Pharma's annual Total Liabilities increased from Mar. 2022 (₹7,912.30 Mil) to Mar. 2023 (₹12,910.30 Mil) but then declined from Mar. 2023 (₹12,910.30 Mil) to Mar. 2024 (₹10,710.30 Mil).

Ajanta Pharma Total Liabilities Historical Data

The historical data trend for Ajanta Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Total Liabilities Chart

Ajanta Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

7,198.20

7,830.90

7,912.30

12,910.30

10,710.30

Ajanta Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															12,910.30	-	9,513.60	-	10,710.30

Ajanta Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ajanta Pharma's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8957.6	+	(235.2	+	1517.5
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10,710

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	46383.9	-	35673.6
	=	10,710

Ajanta Pharma's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8957.6	+	(235.2	+	1517.5
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10,710

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	46383.9	-	35673.6
	=	10,710

Ajanta Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ajanta Pharma (BOM:532331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Total Liabilities

Traded in Other Exchanges

AJANTPHARM:India

Address

Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067

Website

https://www.ajantapharma.com

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines